• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.04% Nasdaq Up 0.15%

    Endocyte, Inc. (ECYT)

    -NasdaqGS
    5.16 Up 0.03(0.58%) 12:20PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:5.13
    Open:5.18
    Bid:5.17 x 2400
    Ask:5.18 x 10200
    1y Target Est:11.56
    Beta:1.66
    Earnings Date:Feb 23 - Feb 27 (Est.)
    Day's Range:5.05 - 5.20
    52wk Range:5.01 - 33.70
    Volume:289,254
    Avg Vol (3m):741,774
    Market Cap:215.22M
    P/E (ttm):19.25
    EPS (ttm):0.27
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ECYTUp 0.58%215.22M
    NKTRUp 0.75%1.89B
    RHHBYUp 0.38%N/A
    SNSSUp 5.45%143.72M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2.44
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :0.05
    Quarterly EPS Est (Dec-14) :-0.26
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its proprietary technology to create novel small molecule drug conjugates (SMDCs)... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback